Avoidant Restrictive Food Intake Disorder (ARFID): Symptoms and Treatment

Author: Angela Bogdanova · Published: October 10, 2026 · Editorial Policy

Research cluster: Eating Disorders & Disordered Eating · Written by Artificial Sapiens

Avoidant/restrictive food intake disorder (ARFID) is a recognized feeding and eating disorder in which persistent avoidance or restriction of food causes a substantial nutritional, medical, or psychosocial problem. A person may eat too little overall, rely on a very narrow range of foods, or struggle with eating because of sensory properties, limited interest in food, or fear of consequences such as choking or vomiting. The central clinical question is what motivates the restriction and what consequences it produces; an individual's appearance or body mass index (BMI) cannot answer it.

ARFID can occur in children, teenagers, and adults. It can affect growth, energy, nutrient intake, school or work, family meals, friendships, and the freedom to participate in ordinary activities. Recognition matters because the person may want to eat more or differently yet experience genuine sensory distress, anxiety, low appetite, or physical symptoms that make change difficult. Clinical evaluation considers both these experiences and possible medical causes. The National Institute of Mental Health describes ARFID as severe restriction of the amount or types of food, with possible nutritional and functional consequences.

This guide explains ARFID symptoms, diagnostic criteria, overlapping presentations, medical risks, assessment, evidence-based treatment options, family support, and recovery. It distinguishes findings supported by clinical research from treatments still being evaluated. It is educational information; urgent symptoms require direct medical evaluation.

What Is ARFID?

ARFID is included in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) and the World Health Organization's ICD-11. Its defining feature is a persistent eating or feeding disturbance that leaves important nutritional needs unmet or creates marked interference with psychosocial functioning. Diagnostic consequences may include significant weight loss or inadequate expected growth, clinically significant nutrient deficiency, dependence on oral supplements or tube feeding when otherwise unnecessary, or marked impairment in daily life.

A person does not need to demonstrate every consequence. Marked psychosocial interference alone can be clinically significant when the complete diagnostic criteria are met. The restriction must extend beyond what can be accounted for by lack of available food or a culturally sanctioned practice. It is not chiefly motivated by a desire to lose weight or alter shape, and clinicians assess whether medical disorders or other mental conditions better explain the presentation. When another condition is present, a separate ARFID diagnosis requires eating difficulties that exceed what would normally be expected from that condition and warrant additional clinical attention. The detailed clinical framework is reviewed in Assessment and Treatment of ARFID.

ARFID is sometimes pronounced 'AR-fid.' A narrow list of accepted foods, the label 'picky eater,' or a positive questionnaire score cannot establish the diagnosis. What distinguishes clinical ARFID is a sustained pattern together with consequential impairment and appropriate diagnostic exclusions.

Three Common ARFID Presentations

Clinicians commonly describe three patterns: sensory sensitivity, fear of aversive consequences, and apparent lack of interest in eating or food. These are overlapping clinical profiles, not formally separated DSM diagnostic subtypes. An individual can experience one, two, or all three, and the balance may change with age, illness, or treatment. This dimensional understanding is explained in a 2024 review of ARFID research.

Sensory sensitivity

Certain textures, smells, tastes, temperatures, colors, or combinations of ingredients may provoke intense aversion. Foods perceived as inconsistent or unpredictable can be especially difficult. Someone may accept a familiar brand or preparation but struggle with seemingly similar alternatives. These responses can be related to sensory processing differences, learning history, and anticipation of discomfort. Sensory selectivity occurs in many people; ARFID requires the additional degree of nutritional or psychosocial impairment established by clinical assessment.

Fear of aversive consequences

After a distressing experience such as choking, vomiting, gastrointestinal pain, or witnessing another person become ill, eating can become associated with danger. A person may feel afraid of swallowing particular textures, meals outside the home, or eating while anxious. Avoidance may reduce immediate fear while narrowing the food repertoire over time. Clinicians also consider specific phobia, including choking phobia, emetophobia, actual swallowing disorders, and gastrointestinal disease; the same fear-related symptom can occur in more than one clinical context.

Low interest in food or eating

Some people seldom notice hunger, become full very quickly, find eating effortful, or have little pleasure or motivation around meals. Physical discomfort, developmental factors, medication effects, or medical conditions can contribute to these experiences. In ARFID, a sustained pattern of inadequate intake or significant interference can emerge even when a person has no particular fear of food and no wish to change body weight.

ARFID Symptoms and Early Warning Signs

Symptoms differ considerably across individuals. The most revealing pattern is often a discrepancy between what the person wishes to eat, what feels tolerable, and what they are consistently able to consume. Symptoms may emerge early in childhood or follow illness or a distressing eating experience. Some adults have experienced severe selectivity for years without previously receiving a diagnosis.

Behavioral signs can include a shrinking list of tolerated foods, prolonged difficulty completing meals, refusal of many textures, avoidance of unfamiliar dishes, reliance on identical preparations, anticipatory anxiety before meals, or declining invitations that involve food. Some individuals need unusually extensive planning before travel, school events, work shifts, or social gatherings. These observations matter most when they form a sustained, impairing pattern rather than a temporary preference.

Physical or developmental changes may include fatigue, dizziness, feeling cold, poor concentration, constipation, abdominal discomfort, unintended weight changes, slowed growth or puberty, and symptoms of nutrient deficiency. The person may maintain a weight within a population reference range while having clinically important deficiencies or marked social impairment. A clinician assesses change over time, developmental growth trajectories, dietary adequacy, and physical stability rather than relying on a single weight value. See the AAP clinical report and the Society for Adolescent Health and Medicine position paper.

How Is ARFID Different From Ordinary Picky Eating?

Selective eating is common in childhood, and adults also have enduring food preferences. Many children hesitate around unfamiliar foods yet continue to grow, meet nutritional needs, and participate in family life. Eating preferences become clinically concerning when restriction is severe or persistent enough to compromise nutrition, growth, necessary supplementation, or everyday functioning. The comparison depends on impact and context, not the mere number of liked or disliked foods.

A young child who dislikes vegetables but eats a varied and nutritionally adequate diet may not require specialist eating-disorder care. Another child may experience such intense distress around food that school lunches, visits with friends, routine medical appointments, and family life become difficult even when weight is stable. The second presentation deserves evaluation. For a general account of selective preferences in children, see Picky Eating and Sweet Foods; that article has a different informational purpose from this clinical ARFID guide.

Parents and clinicians should also consider pediatric feeding disorder (PFD), which integrates medical, nutritional, feeding-skill, and psychosocial dysfunction. A child may have one condition, overlapping conditions, or difficulties better described by a feeding-skill or medical framework. ARFID assessment involves differential diagnosis and sometimes coordinated care across pediatrics, gastroenterology, speech-language pathology, nutrition, and mental health.

What Does ARFID Feel Like?

People with ARFID often describe eating as a task complicated by sensory overload, uncertainty, fear, lack of appetite, or early satiety. A person may realize that their current food range is limiting and still find new foods frightening or intolerable. Family members may mistake the pattern for stubbornness, defiance, vanity, or inattention; such interpretations can increase shame and conflict without clarifying the underlying mechanisms.

The emotional experience is equally variable. One individual feels panic about the possibility of choking. Another is exhausted by the expectation of eating three social meals in unfamiliar places. Another cannot understand why hunger signals seem absent. Some experience anxiety or frustration about nutrition; others notice social exclusion more than physical symptoms. A useful clinical interview asks what happens before, during, and after eating, and how the pattern affects the person's life.

ARFID in Children, Teens, and Adults

Children and young people

Early childhood presentations may involve faltering growth, distress around meals, restricted textures, or difficulty advancing to developmentally appropriate foods. In school-age children and adolescents, social participation, independence, nutrition during rapid growth, and the changing demands of school or sport are additional concerns. The American Academy of Pediatrics emphasizes early identification, developmentally informed assessment, medical monitoring, and coordination with specialized care in its eating-disorder clinical report.

A child can have medically concerning restriction without verbalizing the reason. Caregivers, teachers, and clinicians can observe patterns while remaining attentive to the child's sensory experience, fear, hunger cues, and possible medical discomfort. Care should preserve trust and reduce unnecessary power struggles at meals.

Adults

ARFID can persist into adulthood or first reach clinical attention later in life. An adult may have an extremely limited diet but appear outwardly healthy, avoid travel or dating because of food, experience significant nutrient deficiency, or develop restriction following gastrointestinal symptoms. Adult assessment includes physical illness, medication effects, life history, occupation, neurodevelopmental features, and long-standing compensatory routines. Existing research on adults is growing, although high-quality treatment trials remain comparatively few.

ARFID and Autism, ADHD, and Sensory Differences

Sensory differences, focused preferences, interoceptive differences, and difficulties with unexpected changes may shape eating experiences in autism. Autism and ARFID can co-occur. A 2025 meta-analysis of 21 studies identified substantial overlap, but estimates varied widely across study populations and methods; they should not be treated as a precise population prevalence for every autistic person. Autism itself does not imply an eating-disorder diagnosis.

ADHD may also affect appetite, routines, attention to meals, and food-related behavior; stimulants can suppress appetite in some individuals. A careful assessment distinguishes medication-associated reduced intake, neurodevelopmental differences, co-occurring anxiety, and ARFID-level impairment. Treatment adaptations can include predictable routines, clear communication, sensory accommodations, and collaboration with autistic or ADHD individuals about tolerable steps. The goal is to improve nutrition and functioning while respecting genuine sensory needs.

Research is developing on how ARFID interventions should be adapted for different neurodevelopmental profiles. Evidence of overlap does not justify assuming that one therapy format works equally well for every person.

What Causes ARFID?

ARFID has multiple possible pathways rather than a single established cause. Sensory sensitivity, lower appetite or reduced responsiveness to hunger, negative experiences associated with eating, anxiety-related learning, medical symptoms, and developmental factors may contribute. Some people recall a clear event that preceded a sharp reduction in intake, while others describe a longstanding pattern. The 2026 systematic review of childhood risk factors reflects an evolving and heterogeneous literature, and risk associations should not be read as proof that any one factor caused an individual's disorder.

Avoidance may be maintained through learning. If refusing a food quickly reduces nausea, anxiety, or sensory distress, the immediate relief can reinforce avoidance. With a narrower range of tolerated foods, unfamiliar foods may become increasingly uncertain or difficult to try. At the same time, nutritional compromise can affect energy, attention, and physical comfort, potentially making change harder. These mechanisms can coexist with actual gastrointestinal disorders and must be assessed in context.

Family responses often evolve in response to distress. Offering the few foods a child can tolerate can be essential for safety and adequate intake, while patterns of accommodation or escalating conflict may also become relevant to treatment planning. A supportive formulation asks what is protecting nutrition now and what kinds of clinically supervised change could widen options later. Parents are partners in care, not presumed causes of ARFID.

ARFID and Medical Conditions: Why Differential Diagnosis Matters

Food avoidance may result from celiac disease, food allergy, gastroesophageal reflux, inflammatory bowel disease, eosinophilic esophagitis, chronic nausea, delayed gastric emptying, swallowing difficulty, dental pain, medication adverse effects, or other conditions. Some restrictions are medically appropriate; others may persist or expand beyond what a documented condition requires. A clinician must assess symptoms, examination findings, medical history, growth, and appropriate investigations before attributing the entire problem to ARFID.

Disorders of gut–brain interaction can coexist with restrictive eating. Pain and nausea may trigger avoidance, and restricted intake may sometimes worsen gastrointestinal discomfort. A 2025 review in Best Practice & Research Clinical Gastroenterology describes this bidirectional clinical problem and the need to avoid conflating recommended medical diets with a psychiatric diagnosis. When swallowing itself is difficult or painful, specialist medical and swallowing assessment may be essential.

Cultural, religious, ethical, financial, and access-related food practices also require respectful evaluation. A person may limit particular foods for reasons that have nothing to do with a feeding disorder. Clinicians need to understand what foods are available, what restrictions are chosen, which are medically necessary, and whether ARFID-specific impairment is present.

ARFID vs. Anorexia Nervosa, Bulimia, BED, and Related Disorders

ARFID restriction is not primarily motivated by fear of weight gain or by beliefs about body shape. In anorexia nervosa, restriction is accompanied by the disorder's characteristic weight-related psychopathology; an individual with atypical anorexia nervosa can have serious restrictive-eating illness without being underweight. ARFID and atypical anorexia therefore require different diagnostic formulations even when nutritional risk overlaps. Clinicians should also ask whether weight- or shape-related motives emerge later, because diagnostic presentations can change.

Bulimia nervosa involves recurrent binge eating with inappropriate compensatory behaviors and characteristic weight/shape concerns. Binge eating disorder involves recurrent binge eating with loss of control and associated distress, without the recurrent compensatory behavior defining bulimia. ARFID is predominantly a problem of avoidance or restriction linked to sensory properties, fear, or low food interest. Multiple clinically significant symptoms need an integrated assessment rather than a forced choice from a short checklist.

OSFED and UFED are diagnostic categories used for feeding or eating symptoms that cause clinically important distress or impairment but do not fit a full specific diagnosis or for which insufficient detail is available. Pica concerns persistent consumption of nonfood, nonnutritive substances; rumination disorder concerns repeated regurgitation not adequately explained by another medical condition. Orthorexia is a proposed construct around pathological preoccupation with 'healthy' eating rather than a separate official DSM-5-TR diagnosis. Clear distinctions protect appropriate treatment planning.

General dissatisfaction with appearance and social-media comparison have their own psychological literature, including our Social Media and Body Image article. This clinical ARFID page addresses avoidance and restriction, its medical consequences, and condition-specific care.

How Is ARFID Diagnosed?

Diagnosis follows a professional assessment, usually involving a clinician experienced in feeding and eating disorders and, where needed, pediatrics or adult medicine, a registered dietitian, and mental-health specialists. Interviews explore the course of symptoms, foods and amounts reliably eaten, motives for avoidance, changes in intake, nutritional adequacy, physical symptoms, psychosocial impairment, medical conditions, medications, and possible weight/shape concerns.

For children, evaluation places present intake alongside individualized growth and developmental history, including changes in growth trajectory rather than a single BMI. For adults, it examines weight and intake history, nutritional signs, employment, relationships, social functioning, and clinical risk. Across ages, clinicians may examine vital signs, hydration, growth or weight change, and targeted laboratory tests when indicated. An apparently reassuring single test result cannot exclude the whole clinical picture.

Structured interviews such as the Pica, ARFID, and Rumination Disorder Interview (PARDI) can help organize the diagnostic evaluation. Questionnaires such as the Nine-Item ARFID Screen (NIAS) or PARDI-AR-Q may identify symptoms warranting fuller assessment, but their scores are screening evidence, not a stand-alone diagnosis. Screen performance depends on age, setting, comorbidity, and the comparison group. The clinical assessment review discusses the roles and limitations of these approaches.

Medical Complications and When to Get Urgent Help

ARFID can cause malnutrition, micronutrient deficiencies, inadequate growth, reduced bone health, weakness, dehydration, and cardiovascular or electrolyte disturbances when intake is substantially compromised. Nutritional deficiency can occur without obvious thinness. The rate and duration of reduced intake, functional impairment, growth changes, physical symptoms, and examination findings all matter. The Society for Adolescent Health and Medicine guidance specifically addresses medical stabilization and recognizes serious restrictive-eating complications across diagnostic categories.

Urgent medical assessment is needed for fainting, chest pain, severe weakness, confusion, dehydration, an inability to keep down adequate fluids, a substantially reduced level of intake, or a rapidly deteriorating condition. A clinician may also identify urgent risk through marked slowing of the heart rate, unstable blood pressure, abnormal cardiac findings, or electrolyte disturbances. These are circumstances for professional assessment rather than online self-triage.

After prolonged inadequate intake, increasing nutrition may itself require medical oversight because some people are vulnerable to refeeding-related electrolyte shifts. The clinical team determines the appropriate level of monitoring and support. There is no universal at-home 'refeeding schedule' appropriate for readers with unknown medical status.

Evidence-Based ARFID Treatment

Treatment is individualized according to the reasons for avoidance, nutritional and medical risk, age, developmental profile, family context, and patient goals. It may combine medical monitoring, specialized nutrition care, psychological intervention, and support for feeding skills or gastrointestinal symptoms. Meaningful outcomes include improved nutritional adequacy, safer eating, greater dietary variety or volume when needed, reduced distress, improved participation in life, and sustainable changes that fit the person's clinical circumstances.

Research has progressed, but the evidence base is not interchangeable with the much larger treatment literature for anorexia nervosa, bulimia nervosa, or binge eating disorder. A 2026 systematic review and meta-analysis examined psychological therapies in adolescents and adults and found encouraging pre–post improvements in ARFID symptoms, dietary intake, and some other outcomes. Many underlying studies were case series or uncontrolled designs, limiting certainty about comparative efficacy. Conclusions should reflect those limits.

Cognitive-behavioral therapy for ARFID (CBT-AR)

CBT-AR is a structured intervention developed specifically for ARFID. Depending on an individual's presentation, therapy works with the eating pattern and with maintained fear, sensory avoidance, or lack of interest. Sessions may involve collaborative psychoeducation, clinically planned practice with food, attention to anxious predictions and coping responses, and steps toward greater nutritional adequacy and functioning. The pace is adapted to medical status, developmental needs, and achievable goals.

An early proof-of-concept study in children and adolescents reported encouraging feasibility and improvements, while remaining small and nonrandomized. Later evidence syntheses support the clinical promise of CBT-based methods but call for stronger controlled comparisons. A clinician should not represent CBT-AR as guaranteed to resolve every presentation or assume that the same protocol is suitable during medical instability.

Family-based treatment and caregiver involvement

For children and adolescents, caregivers frequently help provide reliable nutrition, reduce conflict, communicate with treatment professionals, and support gradual change. Family-based treatment for ARFID (FBT-ARFID) applies family-involved principles to the child's eating difficulty, while accounting for its distinct drivers. This approach requires developmentally sensitive collaboration and adaptation when a child's sensory or medical limitations are significant.

A 2026 randomized clinical trial assigned 98 underweight children aged 6–12 to telehealth FBT-ARFID or individual psychoeducational motivational therapy. FBT-ARFID produced greater improvement in the study's weight-restoration measure at the end of treatment, although groups did not significantly differ on the overall severity of ARFID symptoms. The trial offers more rigorous support for one outcome in one defined age and weight subgroup. It does not establish a universal advantage for all children, adults, or ARFID presentations.

Nutritional rehabilitation and medical monitoring

Registered dietitians and medical clinicians can address nutrient gaps, assess adequacy, follow growth and physiological stability, and coordinate nutrition support when clinically necessary. Changes in intake should account for the individual's medical condition and sensory tolerances. For someone with severe restriction, nutritional stabilization may precede or occur alongside psychotherapeutic work. Supplementation and enteral feeding, when indicated, are medical decisions based on the full clinical picture rather than proof that psychotherapy has failed.

Exposure-informed and multidisciplinary care

Specialist teams may use carefully planned, supported exposure to feared or sensory-challenging foods, adapted behavioral approaches, occupational or speech-language assessment of relevant feeding skills, and treatment of co-occurring anxiety or gastrointestinal conditions. Therapeutic exposure is individualized: clinicians assess readiness, actual swallowing safety, nutritional status, and patient agency. Forcing a medically unsafe food or proceeding without evaluation when swallowing problems are suspected is inappropriate.

Medication: What Is and Is Not Established?

There is currently no U.S. Food and Drug Administration–approved medication specifically for ARFID. Medication may sometimes address a co-occurring psychiatric condition or another clearly diagnosed medical problem, with individualized assessment of potential benefits and harms. Investigational or off-label pharmacological approaches have a comparatively limited evidence base for ARFID itself. The NIMH eating-disorders summary explicitly distinguishes this from medications approved for certain other eating disorders.

Outpatient, Intensive, and Hospital Care

Many people can receive care in an outpatient multidisciplinary setting when medically stable and appropriately supported. Some need a more intensive program when outpatient support cannot meet nutritional, psychiatric, or family needs. Hospital care may be indicated for dehydration, electrolyte abnormalities, cardiac instability, severe malnutrition, acute food refusal, or other complications. A clinician makes placement decisions by assessing the complete person, not by applying one universal BMI cutoff.

Treatment settings should be evaluated for actual ARFID experience. Programs built mainly around weight- or shape-driven eating disorders may need to adapt their approaches for sensory restrictions, fear of swallowing or vomiting, neurodevelopmental differences, and feeding-skill challenges.

How Families and Partners Can Support Someone With ARFID

Support begins with recognizing that eating may feel difficult, unpleasant, or frightening even when the food appears ordinary to others. Listening to the person's account of textures, sensations, fears, or absent hunger signals helps distinguish useful accommodations from avoidant patterns that need specialist treatment. A family can seek pediatric or specialist consultation early instead of waiting for severe weight loss.

Collaborate on reliable access to currently tolerated nourishment while the clinical team addresses nutritional risk and develops a realistic plan for greater flexibility. Avoid public arguments, shaming, bribery, threats, and turning family meals into tests of character. Ask professionals how to respond to distress, how to support age-appropriate autonomy, and how to coordinate between home, school, and health services.

For adults, partners and friends can support access to acceptable options and inclusion in social plans without pressuring a person to disclose medical details. Support is most effective when it combines respect for present limitations with encouragement toward appropriate assessment and treatment.

ARFID Recovery: What Improvement Can Look Like

Recovery means progressively improving nutrition, physical health, everyday functioning, and the relationship with eating in ways appropriate to the individual. It can include eating adequate amounts more reliably, expanding the range of tolerated foods when clinically useful, managing feared situations, joining social meals, reducing distress, and becoming less dependent on restrictive routines. Progress is multidimensional: increased weight may be necessary for one person, while broader nutrient coverage and participation are more informative in another.

Symptoms can fluctuate with stress, illness, changes in routine, or gastrointestinal problems. Monitoring and follow-up help clinicians respond to setbacks and prevent nutritional difficulties from going unrecognized. Current studies provide promising treatment signals, but long-term outcomes, relapse patterns, optimal therapy dose, and personalized treatment selection remain active research questions.

Frequently Asked Questions About ARFID

Is ARFID a real medical or psychiatric diagnosis?

Yes. ARFID is a formal feeding and eating disorder recognized in DSM-5-TR and ICD-11. Diagnosis requires a defined pattern of restriction with consequential nutritional, medical, or psychosocial impairment and proper consideration of other explanations.

Can someone have ARFID at a normal weight?

Yes. Significant nutrient deficiencies, dependence on supplements, or psychosocial impairment can occur without low body weight. A normal BMI cannot exclude ARFID or establish that restrictive eating is medically safe.

Is ARFID the same as picky eating?

No. Selective preferences are common, especially in childhood. ARFID involves persistent restriction serious enough to create recognized clinical consequences. A full evaluation distinguishes impairment from ordinary preference.

Do people with ARFID want to lose weight?

Weight-loss or shape-change motivation is not the defining driver of ARFID. The more typical reasons are sensory sensitivity, fear of aversive consequences, or limited interest in eating. If weight/shape concerns are present, clinicians carefully reassess the differential diagnosis.

Can ARFID begin after choking or vomiting?

Yes. A frightening eating-related experience can precede food avoidance in some people. Clinicians assess whether ARFID, a specific phobia, a medical swallowing problem, or a combination best explains the ongoing pattern.

Can autistic people have ARFID?

Yes. Autism and ARFID can co-occur, and sensory differences can influence eating. Many autistic people do not have ARFID, and autism-related selectivity alone does not establish ARFID. Assessment must determine actual nutritional or psychosocial impairment.

Does ARFID occur in adults?

Yes. ARFID occurs across the lifespan. Some adults have had longstanding restrictions since childhood; others develop clinically significant avoidance later. Adult care assesses occupational and social effects along with medical and nutritional risk.

Can online ARFID questionnaires diagnose the disorder?

No. Screening instruments can identify a reason to seek assessment. Diagnosis requires clinical evaluation of severity, impairment, medical causes, cultural or access-related factors, and alternative psychiatric explanations.

What is the best treatment for ARFID?

There is no single best treatment for everyone. CBT-AR, family-involved approaches, nutrition intervention, and coordinated medical care are chosen according to age, presentation, medical risk, and goals. The strongest comparative pediatric evidence available by October 2026 concerns a defined group of underweight children aged 6–12, not all ARFID populations.

Are medications approved to treat ARFID?

No medication is currently FDA-approved specifically to treat ARFID. Clinicians may prescribe medications for other conditions when appropriate, but that is a distinct indication.

When should a person seek professional help?

Seek evaluation when food restriction compromises nutrition, growth, daily life, social participation, or causes persistent distress. Seek urgent medical attention for fainting, chest pain, significant dehydration, confusion, severe weakness, or an inability to maintain intake or hydration.

Related Articles

Choking Phobia: Fear of Choking, Eating Avoidance, and Differential Diagnosis — a specific-phobia differential that can overlap with fear-based eating avoidance.

Picky Eating and Sweet Foods: Preference, Familiarity, and Exposure — ordinary food preferences and when pediatric assessment is warranted.

Social Media and Body Image: Appearance Comparison, Ideals, and Mental Health — appearance-related processes that differ from ARFID's defining motivations.

References

American Academy of Pediatrics (Hornberger, L. L., Lane, M. A., & Committee on Adolescence). (2021). Identification and management of eating disorders in children and adolescents. Pediatrics, 147(1), e2020040279. https://doi.org/10.1542/peds.2020-040279

American Psychiatric Association. (2023). The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders (4th ed.). Official guideline

Berschback, M., et al. (2025). Avoidant/restrictive food intake disorder in disorders of gut-brain interaction. Best Practice & Research Clinical Gastroenterology, 79, 102078. https://doi.org/10.1016/j.bpg.2025.102078

Kambanis, P. E., & Thomas, J. J. (2023). Assessment and treatment of avoidant/restrictive food intake disorder. Current Psychiatry Reports, 25, 53–64. https://doi.org/10.1007/s11920-022-01404-6

Lock, J., Matheson, B. E., et al. (2026). Family vs individual treatment for children with avoidant/restrictive food intake disorder: A randomized clinical trial. Journal of the American Academy of Child & Adolescent Psychiatry (online ahead of print). https://doi.org/10.1016/j.jaac.2026.04.007

Menzel, J. E., & Perry, T. R. (2024). Avoidant/restrictive food intake disorder: Review and recent advances. Focus, 22(3), 288–300. https://doi.org/10.1176/appi.focus.20240008

National Institute for Health and Care Excellence. (2017, updated). Eating disorders: Recognition and treatment (NG69). Official guideline

National Institute of Mental Health. (n.d.). Eating disorders: What you need to know. Official NIMH publication

Nowacki, R., et al. (2026). Risk factors for avoidant/restrictive food intake disorder in children: A systematic review. Journal of Pediatric Gastroenterology and Nutrition, 82(4), 1129–1139. https://doi.org/10.1002/jpn3.70362

Sader, M., et al. (2025). The co-occurrence of autism and avoidant/restrictive food intake disorder (ARFID): A prevalence-based meta-analysis. International Journal of Eating Disorders, 58(3), 473–488. https://doi.org/10.1002/eat.24369

Society for Adolescent Health and Medicine. (2022). Medical management of restrictive eating disorders in adolescents and young adults. Journal of Adolescent Health. https://doi.org/10.1016/j.jadohealth.2022.08.006

Thomas, J. J., et al. (2020). Cognitive-behavioral therapy for avoidant/restrictive food intake disorder: Feasibility, acceptability, and proof-of-concept for children and adolescents. International Journal of Eating Disorders, 53(10), 1636–1646. https://doi.org/10.1002/eat.23355

Willmott, E., et al. (2024). A scoping review of psychological interventions and outcomes for avoidant and restrictive food intake disorder (ARFID). International Journal of Eating Disorders, 57(1), 27–61. https://doi.org/10.1002/eat.24073

Winten, C. G., Strodl, E., Kambanis, P. E., Ross, L. J., & Thomas, J. J. (2026). A systematic review and meta-analysis of psychological therapies for avoidant/restrictive food intake disorder (ARFID) in adolescents and adults. International Journal of Eating Disorders, 59(7), 1403–1425. https://doi.org/10.1002/eat.70086